Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: The framework for monitoring

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Alcalde Cabero, Enrique ^a   Almazán Isla, Javier ^a   García Merino, Antonio ^b   de Sá, Joao ^c   de Pedro Cuesta, Jesús ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Incidence; Monitoring; Multiple sclerosis; Surveillance; Time trends

Indexed keywords

AGE; ARTICLE; DENMARK; EPIDEMIOLOGICAL MONITORING; EUROPE; FRANCE; GREECE; HEALTH SURVEY; HUMAN; ICELAND; INCIDENCE; ITALY; LATITUDE; MULTIPLE SCLEROSIS; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; SEX; SPAIN; SYSTEMATIC REVIEW; UNITED KINGDOM;

ADULT; AGE FACTORS; DATABASES, FACTUAL; EUROPE; EUROPEAN UNION; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84878818145     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-58     Document Type: Article

References (73)

1. Fogdell A, Olerup O, Fredrikson S, Vrethem M, Hillert J. Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis. Neurology 1997, 48:758-762. 10.1212/WNL.48.3.758, 9065561.
2. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219. 10.1038/nature10251, 3182531, 21833088.
3. Baranzini SE, Nickles D. Genetics of multiple sclerosis: swimming in an ocean of data. Curr Opin Neurol 2012, 25:239-245. 10.1097/WCO.0b013e3283533a93, 22516854.
4. Jin Y, de Pedro-Cuesta J, Soderstrom M, Stawiarz L, Link H. Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci 2000, 181:56-64. 10.1016/S0022-510X(00)00408-1, 11099713.
5. Jin YP, de Pedro-Cuesta J, Lopez-Abente G, Link H. Birth cohort effects in multiple sclerosis. Ann Epidemiol 2003, 13:252-260. 10.1016/S1047-2797(02)00278-8, 12684191.
6. Hawkes CH, Macgregor AJ. Twin studies and the heritability of MS: a conclusion. Mult Scler 2009, 15:661-667. 10.1177/1352458509104592, 19482860.
7. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995, 47:425-448.
8. Cabre P. Environmental changes and epidemiology of multiple sclerosis in the French West Indies. J Neurol Sci 2009, 286:58-61. 10.1016/j.jns.2009.04.039, 19520388.
9. Benito-Leon J. Are the prevalence and incidence of multiple sclerosis changing?. Neuroepidemiology 2011, 36:148-149. 10.1159/000325368, 3095836, 21508647.
10. Nicoletti A, Patti F, Lo Fermo S, Messina S, Bruno E, Quattrocchi G, Laisa P, Cilia S, Mostile G, Marziolo R, et al. Increasing frequency of multiple sclerosis in Catania, Sicily: a 30-year survey. Mult Scler 2011, 17:273-280. 10.1177/1352458510386995, 21071466.
11. Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 2004, 63:838-842. 10.1212/01.WNL.0000138433.61870.82, 15365133.
12. Flachenecker P, Stuke K. National MS registries. J Neurol 2008, 255(Suppl 6):102-108.
13. Ahlgren C, Oden A, Toren K, Andersen O. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol Scand 2009, 119:313-320. 10.1111/j.1600-0404.2008.01131.x, 19154535.
14. Otero S, Batlle J, Bonaventura I, Brieva L, Bufill E, Cano A, Carmona O, Escartin A, Marco M, Moral E, et al. Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia. Rev Neurol 2010, 50:623-633.
15. Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 2011, 343:d5956. 10.1136/bmj.d5956, 3192001, 21994316.
16. de Sa J, Alcalde-Cabero E, Almazan-Isla J, Sempere A, de Pedro-Cuesta J. Capture-recapture as a potentially useful procedure for assessing prevalence of multiple sclerosis: methodologic exercise using portuguese data. Neuroepidemiology 2012, 38:209-216. 10.1159/000337534, 22555496.
17. Esbjerg S, Keiding N, Koch-Henriksen N. Reporting delay and corrected incidence of multiple sclerosis. Stat Med 1999, 18:1691-1706. 10.1002/(SICI)1097-0258(19990715)18:13<1691::AID-SIM160>3.0.CO;2-D, 10407238.
18. Thygesen LC, Keiding N, Koch-Henriksen N. Evaluating a parametric model to correct multiple sclerosis incidence for reporting delay. Stat Med 2011, 30:896-898. 10.1002/sim.4111, 21432886.
19. Joensen P. Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands. Mult Scler 2011, 17:241-244. 10.1177/1352458510386997, 20978036.
20. Koch-Henriksen N, Bronnum-Hansen H, Hyllested K. Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study. Neuroepidemiology 1992, 11:1-10.
21. Kurtzke JF, Heltberg A. Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol 2001, 54:1-22. 10.1016/S0895-4356(00)00268-7, 11165464.
22. Poskanzer DC, Schapira K, Miller H. Epidemiology of multiple sclerosis in the counties of Northumberland and Durham. J Neurol Neurosurg Psychiatr 1963, 26:368-376. 10.1136/jnnp.26.4.368, 495598, 14061020.
23. Debouverie M. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France. J Neurol Sci 2009, 286:14-17. 10.1016/j.jns.2009.07.012, 19691994.
24. Krokki O, Bloigu R, Reunanen M, Remes AM. Increasing incidence of multiple sclerosis in women in Northern Finland. Mult Scler 2011, 17:133-138. 10.1177/1352458510384012, 20935028.
25. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008, 71:129-135. 10.1212/01.wnl.0000316802.35974.34, 18606967.
26. Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 2001, 8:463-469. 10.1046/j.1468-1331.2001.00269.x, 11554910.
27. Granieri E, Casetta I, Govoni V, Tola MR, Marchi D, Murgia SB, Ticca A, Pugliatti M, Murgia B, Rosati G. The increasing incidence and prevalence of MS in a Sardinian province. Neurology 2000, 55:842-848. 10.1212/WNL.55.6.842, 10994006.
28. Ranzato F, Perini P, Tzintzeva E, Tiberio M, Calabrese M, Ermani M, Davetag F, De Zanche L, Garbin E, Verdelli F, et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler 2003, 9:387-392. 10.1191/1352458503ms920oa, 12926844.
29. Pai M, McCulloch M, Gorman JD, Pai N, Enanoria W, Kennedy G, Tharyan P, Colford JM. Systematic reviews and meta-analyses: an illustrated, step-by-step guide. Natl Med J India 2004, 17:86-95.
30. Alstadhaug KB, Olavsen J, Salvesen R. [Occurrence of multiple sclerosis in Nordland, 1970-1999]. Tidsskr Nor Laegeforen 2005, 125:431-433.
31. Debouverie M, Pittion-Vouyovitch S, Louis S, Roederer T, Guillemin F. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler 2007, 13:962-967. 10.1177/1352458507077938, 17623734.
32. Nicoletti A, Patti F, Lo Fermo S, Sorbello V, Reggio E, Maimone D, Zappia M, Reggio A. Possible increasing risk of multiple sclerosis in Catania, Sicily. Neurology 2005, 65:1259-1263. 10.1212/01.wnl.0000180628.38786.85, 16247054.
33. Cocco E, Sardu C, Massa R, Mamusa E, Musu L, Ferrigno P, Melis M, Montomoli C, Ferretti V, Coghe G, et al. Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 2011, 17:1282-1289. 10.1177/1352458511408754, 21652610.
34. Granieri E, Economou NT, De Gennaro R, Tola MR, Caniatti L, Govoni V, Fainardi E, Casetta I. Multiple sclerosis in the province of Ferrara : evidence for an increasing trend. J Neurol 2007, 254:1642-1648. 10.1007/s00415-007-0560-5, 18008026.
35. Granieri E, Monaldini C, De Gennaro R, Guttmann S, Volpini M, Stumpo M, Fazio P, Casetta I. Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study. Mult Scler 2008, 14:325-329. 10.1177/1352458507084114, 18208882.
36. Guidetti D, Cavalletti S, Merelli E, Zanoni P, Simonazzi P, Sola P, Solime F. Epidemiological survey of multiple sclerosis in the provinces of Reggio Emilia and Modena, Italy. Neuroepidemiology 1995, 14:7-13. 10.1159/000109772, 7898604.
37. Sundstrom P, Nystrom L, Forsgren L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J Neurol Neurosurg Psychiatr 2003, 74:29-32. 10.1136/jnnp.74.1.29, 1738162, 12486262.
38. Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatr 2009, 80:386-391.
39. Grimaldi LM, Salemi G, Grimaldi G, Rizzo A, Marziolo R, Lo Presti C, Maimone D, Savettieri G. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology 2001, 57:1891-1893. 10.1212/WNL.57.10.1891, 11723283.
40. Joensen P. Multiple sclerosis incidence in the Faroe Islands 1986-2007. Acta Neurol Scand 2010, 121:348-353. 10.1111/j.1600-0404.2009.01252.x, 20015109.
41. Ragonese P, Salemi G, D'Amelio M, Gammino M, Aridon P, Savettieri G. Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study. Neuroepidemiology 2004, 23:306-309. 10.1159/000080097, 15297798.
42. Salemi G, Ragonese P, Aridon P, Scola G, Saporito V, Conte S, Savettieri G. Incidence of multiple sclerosis in Bagheria City, Sicily, Italy. Neurol Sci 2000, 21:361-365. 10.1007/s100720070051, 11441573.
43. Granieri E, Malagu S, Casetta I, Tola MR, Govoni V, Paolino E, Monetti VC. Multiple sclerosis in Italy. A reappraisal of incidence and prevalence in Ferrara. Arch Neurol 1996, 53:793-798. 10.1001/archneur.1996.00550080115019, 8759986.
44. Nicoletti A, Lo Bartolo ML, Lo FS, Cocuzza V, Panetta MR, Marletta C, Ciancio MR, Cataldi ML, Patti F, Reggio A. Prevalence and incidence of multiple sclerosis in Catania, Sicily. Neurology 2001, 56:62-66. 10.1212/WNL.56.1.62, 11148237.
45. Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Pirastru MI, Murgia B, Mannu L, Sanna G, Rosati G. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand 2001, 103:20-26. 10.1034/j.1600-0404.2001.00207.x, 11153884.
46. Eliasdottir OJ, Olafsson E, Kjartansson O. Incidence of multiple sclerosis in Iceland, 2002-2007: a population-based study. Mult Scler 2011, 17:909-913. 10.1177/1352458511402112, 21511690.
47. Cavalletti S, Merelli E, Cavazzuti M, Guidetti D. Frequency of MS in the province of Modena, 1970-1990. Acta Neurol Scand 1994, 90:377-381.
48. Alonso A, Jick SS, Olek MJ, Hernan MA. Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort. J Neurol 2007, 254:1736-1741. 10.1007/s00415-007-0602-z, 17896096.
49. Benedikz J, Stefansson M, Guomundsson J, Jonasdottir A, Fossdal R, Gulcher J, Stefansson K. The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study. Clin Neurol Neurosurg 2002, 104:208-210. 10.1016/S0303-8467(02)00040-9, 12127656.
50. Gronlie SA, Myrvoll E, Hansen G, Gronning M, Mellgren SI. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J Neurol 2000, 247:129-133. 10.1007/PL00007793, 10751116.
51. Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 2006, 66:182-186. 10.1212/01.wnl.0000195549.95448.b9, 16434650.
52. Midgard R, Riise T, Svanes C, Kvale G, Nyland H. Incidence of multiple sclerosis in More and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis. Brain 1996, 119(Pt 1):203-211.
53. Piperidou HN, Heliopoulos IN, Maltezos ES, Milonas IA. Epidemiological data of multiple sclerosis in the province of Evros, Greece. Eur Neurol 2003, 49:8-12. 10.1159/000067020, 12464712.
54. Pugliatti M, Riise T, Sotgiu MA, Sotgiu S, Satta WM, Mannu L, Sanna G, Rosati G. Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology 2005, 25:129-134. 10.1159/000086677, 15990443.
55. Risberg G, Aarseth JH, Nyland H, Lauer K, Myhr KM, Midgard R. Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurol Scand 2011, 124:250-257.
56. Rosati G, Aiello I, Pirastru MI, Mannu L, Sanna G, Sau GF, Sotgiu S. Epidemiology of multiple sclerosis in Northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 1996, 15:10-19. 10.1159/000109884, 8719044.
57. Mallada-Frechin J, Matias-Guiu GJ, Martin R, Lopez-Arlandis JM, Camacho-Cuartero JM, Beltran I, Molto JM, Falip R, Abellan-Miralles I. Multiple sclerosis incidence in the Alcoi Health district. 12-year-long study (1986-1997). Rev Neurol 2000, 30:1128-1131.
58. Modrego PJ, Pina MA. Trends in prevalence and incidence of multiple sclerosis in Bajo Aragon, Spain. J Neurol Sci 2003, 216:89-93. 10.1016/j.jns.2003.07.007, 14607307.
59. Sumelahti ML, Tienari PJ, Hakama M, Wikstrom J. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses. J Neurol Neurosurg Psychiatr 2003, 74:25-28. 10.1136/jnnp.74.1.25, 1738192, 12486261.
60. Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M. Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey. Neuroepidemiology 2008, 30:167-173. 10.1159/000122334, 18382116.
61. Fernandez O, Fernandez V, Arbizu T, Izquierdo G, Bosca I, Arroyo R, Garcia Merino JA, de RE. Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (the Novo Study). J Neurol 2010, 257:1500-1507. 10.1007/s00415-010-5560-1, 20383518.
62. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302. 10.1002/ana.22366, 3084507, 21387374.
63. Bostrom I, Stawiarz L, Landtblom AM. Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg). Mult Scler 2013, 19:46-52. 10.1177/1352458512446169, 22711712.
64. Barnett MH, Williams DB, Day S, Macaskill P, McLeod JG. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci 2003, 213:1-6. 10.1016/S0022-510X(03)00122-9, 12873746.
65. Alter M. Multiple sclerosis in the Negro. Arch Neurol 1962, 7:83-91. 10.1001/archneur.1962.04210020005001, 13860726.
66. Fischman HR. Multiple sclerosis: a two-stage process?. Am J Epidemiol 1981, 114:244-252.
67. Fischman HR. Multiple sclerosis: a new perspective on epidemiologic patterns. Neurology 1982, 32:864-870. 10.1212/WNL.32.8.864, 7201582.
68. Cabre P. Migration and multiple sclerosis: the French West Indies experience. J Neurol Sci 2007, 262:117-121. 10.1016/j.jns.2007.06.044, 17651756.
69. Jeannin S, Deschamps R, Chausson N, Cabre P. Response to interferon-Beta treatment in afro-caribbeans with multiple sclerosis. Mult Scler Int 2011, 2011:950126. 3195322, 22096646.
70. Mancardi GL, Tedeschi G, Amato MP, D'Alessandro R, Drago F, Milanese C, Popoli P, Rossi P, Savettieri G, Tola MR, et al. Three years of experience: the Italian registry and safety data update. Neurol Sci 2011, 31(Suppl 3):295-297.
71. Piehl F, Holmen C, Hillert J, Olsson T. Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci 2011, 31(Suppl 3):289-293.
72. Ahlgren C, Oden A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 2011, 17:901-908. 10.1177/1352458511403794, 21459810.
73. Cuadrado JI, de Pedro-Cuesta J, Ara JR, Cemillan CA, Diaz M, Duarte J, Fernandez MD, Fernandez O, Garcia-Lopez F, Garcia-Merino A, et al. Public health surveillance and incidence of adulthood Guillain-Barre syndrome in Spain, 1998-1999: the view from a sentinel network of neurologists. Neurol Sci 2004, 25:57-65.